rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    NTRA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Natera Short Interest Rises As Bets Remain Near September Peak
      Nov 17BenzingaNTRA
      Why Is Natera Stock Up Nearly 41% Since May?
      Nov 17Yahoo FinanceNTRA
      Natera CFO Maps Multiple Paths to $6 Billion Revenue Target by 2029
      Nov 15Yahoo FinanceNTRA
      Natera CFO Defends CEO Switch, Calls $6 Billion Revenue Target a “Way Station”
      Nov 14Yahoo FinanceNTRA
      Natera co-founder Sheena sells $478,944 in common stock
      Nov 14Investing.comNTRA
      ETFs Are Net Sellers of Natera (NTRA) on Wednesday
      Nov 13Yahoo FinanceNTRA
      How Incyte Trial And New Cancer Data Will Impact Natera Stock
      Nov 13Yahoo FinanceINCYNTRA
      Natera (NTRA) Following Clinical Momentum Looks Fully Valued To Some
      Nov 13Yahoo FinanceNTRA
      The Fund Exited Natera (NTRA) on Valuation Concerns Despite Strong Fundamentals
      Nov 11Yahoo FinanceNTRA
      Strong Q2 Results and Raised Revenue Guidance Drive Natera’s (NTRA)Outperformance
      Nov 11Yahoo FinanceNTRA
      Natera and Incyte partner on Phase II colorectal cancer trial
      Nov 11Yahoo FinanceINCYNTRA
      Natera director Jonathan Sheena sells $995,404 in stock
      Nov 11Investing.comNTRA
      Natera at Wolfe healthcare conference: leadership shift, bold growth plan
      Nov 10Investing.comNTRA
      Natera, Incyte partner on colorectal cancer trial using MRD test
      Nov 10Investing.comINCYNTRA
      Natera Announces Clinical Collaboration with Incyte on Interventional Phase II Study in Colorectal Cancer
      Nov 10Yahoo FinanceINCYNTRA
      NTRA Q3 Loss Wider Than Expected, Revenues Beat, '26 Sales View Up

      Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

      Nov 9The Globe and MailNTRA
      Cathie Wood’s ARK sells CareDx stock, buys Natera and Kratos
      Nov 7Investing.comCDNANTRA
      Natera Stocks Slide 15.07% After Wider Loss and Sudden CEO Change
      Nov 6Yahoo FinanceNTRA
      Natera (NTRA) Q3 2026 Earnings Call Transcript | The Motley Fool

      Natera's new CEO outlines a path to double revenue by 2029

      Nov 6The Motley FoolNTRA
      Natera Stock Plummets After Mixed Q3 Financials
      Nov 6BenzingaNTRA
      If You Invested $100 In Natera Stock 10 Years Ago, You Would Have This Much Today
      Nov 6BenzingaNTRA
      Piper Sandler reiterates Natera stock rating on CEO transition
      Nov 6Investing.comNTRA
      Natera, Inc. Q3 2026 Earnings Call Summary
      Nov 6Yahoo FinanceNTRA
      DraftKings Posts Downbeat Q3 Results, Joins Atlassian, Natera And Other Big Stocks Moving Lower In Friday
      Nov 6BenzingaDKNGNTRATEAM
      Why is Natera stock tumbling today?
      Nov 6Investing.comNTRA
      What Natera (NTRA) Said on Its Q3 Earnings Call
      Nov 6Yahoo FinanceNTRA
      Natera Inc (NTRA) Q3 2026 Earnings Call Highlights: Revenue Jumps 34% as Guidance Raised Above ...

      Natera Inc (NTRA) posted record test volumes and 56% growth in clinical MRD units, prompting a $140 million midpoint guidance hike and a bold $6 billion revenue target for 2029.

      Nov 6Yahoo FinanceNTRA
      Natera (NTRA) Reports Q3 Loss, Beats Revenue Estimates
      Nov 6Yahoo FinanceNTRA
      Natera Inc earnings missed by $0.15, revenue topped estimates
      Nov 5Investing.comNTRA
      Natera Q3 2026 Earnings Call Transcript
      Nov 5BenzingaNTRA
      Natera: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceNTRA
      Natera appoints Solomon Moshkevich as new CEO
      Nov 5Investing.comNTRA
      Natera (NASDAQ:NTRA) delivers impressive Q3 2026 but stock drops 19.7%
      Nov 5Yahoo FinanceNTRA
      Blood-Testing Gore Continues As Natera, Guardant Report

      Shares of both plummeted following their third-quarter reports.

      Nov 5Investor's Business DailyGHNTRA
      Natera Announces Leadership Transition
      Nov 5Yahoo FinanceNTRA
      Natera Reports Third Quarter 2026 Financial Results
      Nov 5Yahoo FinanceNTRA
      Signatera™ Monitoring During First-Line Immunotherapy Showed ctDNA Clearance is Associated with Long-Term Survival Across Four Metastatic Cancers
      Nov 5Yahoo FinanceNTRA
      Natera executive chairman Matthew Rabinowitz sells $299,214 in shares
      Nov 5Investing.comNTRA
      Natera CEO Steven Chapman sells $1.56 million in Natera common stock
      Nov 5Investing.comNTRA
      Natera co-founder director Jonathan Sheena sells $44,796 in shares
      Nov 5Investing.comNTRA
      Natera chief legal officer sells $136,415 in shares
      Nov 5Investing.comNTRA
      Natera CFO Michael Brophy sells $313,997 of NTRA shares
      Nov 5Investing.comNTRA
      Natera president Solomon Moshkevich sells $1.4M stock
      Nov 5Investing.comNTRA
      What Just Happened To Natera Stock?
      Nov 3Yahoo FinanceNTRA
      Medicare Expands Coverage for Signatera™ MRD Test in Hepatocellular Carcinoma
      Nov 3Yahoo FinanceNTRA
      Natera CFO Michael Brophy sells $1.31 million in common stock
      Oct 31Investing.comNTRA
      Natera, Shake Shack, eBay And More On CNBC’s ‘Final Trades’
      Oct 30BenzingaEBAYNTRASHAK
      Natera director Jonathan Sheena sells $197,871 in company stock
      Oct 30Investing.comNTRA
      Natera president Moshkevich sells $905K in company stock
      Oct 30Investing.comNTRA
      Natera president John Fesko sells $699,939 in common stock
      Oct 30Investing.comNTRA

      This is the newest page. Registered accounts read further back.